You are on page 1of 16

VISITNOTE

PATANJALIAYURVED
Waitinginthewings
IndiaEquityResearch|ConsumerGoods

We recently visited Patanjali Ayurveds (Patanjali) Food and Herbal Park EDELWEISSRATINGS
atHaridwarandmetthemanagementteam.Itisoneofthelargestfood
AbsoluteRating UNLISTED
and herbal parks in the world equipped with worldclass manufacturing
machinery and R&D facility. Management has set a revenue target of
~INR5060bninFY16(INR20.2bninFY15)andisconfidentofachievingit,
ledbyitspresenceinmostconsumercategories.Thecompanyisworking
onpluggingthegapsinthesupplychainanddistributionwithplansafoot
toimplementERP(forbetterinventorymanagement)andconsolidateits
online presence. Strong innovation and new products pipeline, pricing
discountstothepeers(1530%),ayurvedicandnaturalpropositionswith
low A&P spends (leveraging Baba Ramdevs brand pull) lend Patanjalis
productsanedgeovercompetition.However,distributionremainsakey
monitorable.

Thrustonrevenueoverprofitability;onlinemovestospurgrowth
Despitebeingacorporateentity,PatanjaliadherestoBabaRamdevsconsumercentric
ideologies.Hence,thefocusisonrevenueandnotprofitability.Thecompanyiswellon
course to achieve its targeted revenue of ~INR5060bn in FY16 (INR20.2bn in FY15).
Even though the thrust is not on profitability, the company managed to clock ~20%
EBITDA margin in FY15, aided by better cost management (latest machinery and
strongR&Dcapabilities)andlowerA&Pspends.Toimproveitsdistributionreach,itis
strengtheningitsonlinepresence.PatanjaliisalsoimplementingERPwhichwillhelp
ininventorymapping.Shortly,amobileappwillalsobelaunchedtohelplocateretail
outletsandforonlineorderingofPatanjaliproducts.

Newproductpipelinestrongandinnovative
Patanjali boasts of a strong new products pipeline. The products are not only
innovative, but reasonably priced too. A central R&D facility equipped with latest
techology along with a separate new product department have helped in lining up a
series of new launches over next few months. The new launches pipeline includes:
Patanjali Noodles, Dant Kanti Advance, Sugar free Chyawanprash, PowerVita,
Seabuckthorndietarysupplementandpowderedhairdye,amongothers.

AbneeshRoy
Aforcetoreckonwith +912266203141
OverFY1215,PatanjaliregisteredrevenueCAGRof64.7%.Thecompanyhasaggressive abneesh.roy@edelweissfin.com
plan to enter every consumer category (keeping aside those that impact lifestyle and
PoojaLath
health).Atthecurrentjuncture,thoughitspresenceinmanycategoriesmaynotqueer
+912266203075
the pitch for other consumer goods companies (each category not too big to impact pooja.lath@edelweissfin.com
except Ghee, which is expected to be INR12bn in FY16), over the long term, gaining
TanmaySharma
palpable distribution prowess could pose a serious threat to competition. Patanjalis
+912240407586
proactive moves in innovation have been crucial for its growth. Other consumer tanmay.sharma@edelweissfin.com
companieswillneedtostepupinnovations,particularlyintheherbalandayurvedic
space(distributionstrengthwillcomehandy)tocountercompetition. October1,2015

EdelweissResearchisalsoavailableonwww.edelresearch.com,
1 EdelweissSecuritiesLimited
BloombergEDEL<GO>,ThomsonFirstCall,ReutersandFactset.
ConsumerGoods

The3principlesvitalforgrowth
Patanjali Ayurved is a incorporated company under the Companies Act Patanjali Ayurved
Limited. Though a corporate entity, its working and ideology is not completely that can be
comparedtothatofaperfectcorporateculture.Thecompanyisfocussedontoplinegrowth
ratherthanprofitability.ItsbusinessideologyisinspiredbySwamiRamdevsideologiesto
toucheverylifethroughPatanjaliwhichwillhelptheconsumersandbepresentinallthe
segments where the consumers feel they can get a better product at a better price. The
organisationconductsitsbusinessonthefollowing3mainprinciples:

(1) Providing worldclass products to consumers (making sure the company does not add
anypreservativesorusesnaturalpreservativesasfaraspossible).

(2) Producing products in the most costeffective manner so that the products are priced
veryreasonably.

(3) Whatever profits the company earns are ploughed back into business so that it can
invest the same for launch of new products, cost effectiveness or further capacity
expansion.

Patanjali will not launch any products that are harmful to the health of consumers and
detrimental to the health and lifestyle of the people. Hence, the company will not get into
product categories like tobacco and liquor which are bad for health. Going forward, the
companyalsoplanstoopen500600branchesofAcharyakulam(educationalinstitutions).

Fig.1:The3vitalprinciplesthatdrivePatanjalisbusiness


Source:Company,Edelweissresearch






2 EdelweissSecuritiesLimited
PatanjaliAyurved

Table1:Productcatalogue
GroceryandStaples DalsandPulses
EdibleOil&Ghee Ghee,MustardOil
Flour/Atta Atta,Besan,Others
Staples/Spices Spices,Salt,Rice

ReadyFood Confectionery Biscuits,Cookies,Candies


Snacks&Breakfast Honey,Papad,snacks,Namkeek
Sauces&Pickles Ketchup,Pickles
Sweets Murabba,SoanPapdi

Beverages Juices&FruitDrinks Apple,Amla,Litchi


Sharbat&Squash Squash,Sharbat

PerosnalCare FaceCare FaceCream,LipCare,Facewash


BodyCare BodyWash,Footcare,Lotions
HairCare Shampoo,Conditioner,HairOil,Hair
Color
Soaps&Handwash Handwash,soaps
OralCare Toothbrush,paste
Makeup Kajal
ShavingandGrooming ShaveGel,Shavecream

HealthCare HealthDrinks,Chyawanprash,
Nutrition&Supplements,
Digestives

Households Worshiprelated,Cleaning&
Washing,HerbalGulal

Source:Company,Edelweissresearch

Targetingmorethan250%revenuegrowthinFY16
Patanjaliclockedrevenueof~INR20.3bninFY15withEBITDAmarginof~20%.Thecompany
targets to achieve revenue of INR5060bn in FY16 itself. Growth is being driven by the
companyslargestsellingproduct,cowsghee(expectedtobeINR12bninFY16)followedby
DantKantiandKeshKanti.Patanajalialsohasarobustpipelineofnewproducts,whichwill
helpachieveitstarget.

Patanjali operates via 3 business segments, viz., foods (foods, supplements, digestives,
dairy, juices, etc), FMCG (cosmetics (shampoo, soaps, facewash), home care (detergent
cakes,powder,liquid),etc)andayurvedicproducts(healthcareproductsforbloodpressure,
skindiseases,jointpain,etc).InFY15,ofthetotalsalesofINR20.3bn,foodandcosmetics
contributedINR8bneach,whilehealthcareproductscomprisedthebalance.Thecompany
hasadequatecapacitytoachieveitsrevenuetargetofINR5060bninFY16.




3 EdelweissSecuritiesLimited
ConsumerGoods

Chart1:Salestrajectory
23,000
TotalIncome

19,000

15,000

(INRmn)
11,000

7,000

3,000
FY12 FY13 FY14 FY15
TotalIncome


Chart2:PATtrend
3,500
NetProfit

2,800

2,100
(INRmn)

1,400

700

0
FY12 FY13 FY14 FY15
NetProfit


Chart3:Revenuemix

TotalIncomeComposition
HealthCare
Ayurvedic
21%

Food
40%

FMCG
(cosmetics,hom
ecare)
39%
Source:Company,Edelweissresearch

4 EdelweissSecuritiesLimited
PatanjaliAyurved

AspirestobepartofeverySKUinkitchen
Patanjaliisworkingonakitchenconcept,aspartofwhichitwilllaunchproductsthatwill
touch all categories of the SKUs used in an Indian kitchen. For instance, the company
alreadyhasproductsthatareusedintheIndiankitchensuchasdishwashbar,ghee,rice(has
3 variants of rice), pulses, spices, mustard oil, flour and madhuram (replacement for sugar
madeoutofjaggery)underthePatanjalibrandname.

Fig.2:SomePatanjaliproductsusedintheIndiankitchen































Source:Company,Edelweissresearch

5 EdelweissSecuritiesLimited
ConsumerGoods

Attractivepricing,naturalpositioningensurecompetitiveness
Patanjaliskeystrength,apartfromitssuperiorproductquality,liesinpricing.Thecompanys
products are priced at ~1530% discount to competition, which makes it an attractive
proposition for consumers. It is able to offer such discounts primarily because of having
negligible A&P spend versus other consumer companies which have A&P spends ranging
from 1218%, as a % of sales. Another reason for the discounts is the consumercentric
ideologyoftheorganisationandsellingbestqualityproductsatattractivepricepoints.There
mayevenbesomeproductsinthecompanysportfoliowhicharemakinglossesorfetchlow
margins,butitcontinuestoselltheseproductstomeetconsumerneeds.

Table2:PricingofPatanjaliproductsversusotherconsumergoodscompanies
Patanjali Comparable
ProductName Qty ProductsPrices Price ComparableCompany Discount
SpecialChyawanprash 500gm 115 160 DaburChyawanprash 28.1%
PineappleJuice 1Ltr 85 99 DaburRealJuice 14.1%
CowGhee 1Ltr 450 710 ParsidairyfarmCowgheepure 36.6%
Honey 500gm 135 199 DaburHoney 32.2%
PatanjaliSaundrayaFaceWash 60gm 60 80 PearsFaceWash 25.0%
PatanjaliKeshKantiAntiDandruffShampoo 200gm 110 159 Head&SholdersAntiDandruffShampoo 30.7%
PatanjaliDantKanti(ToothPaste) 200gm 68 84 PepsodentGermicheck 19.0%
PatanjaliKantiNeemBathingSoap 75gm 15 24 HimalayaNeem&Turmeric 37.5%
PatanjaliSuperDishWashBar 175gm 10 15 VIMDishwasBar 32.8%
PatanjaliCornFlakesMix 500gm 145 182 KelloggsCornFlakesOriginal 20.2%
PatanjaliDetergentPowderPopular 250gm 13 19 RINDetergentPowder 31.6%
Source:Edelweissresearch

Lowerandeffectiveadvertisingaidslowerpricing
PatanjaliAyurvedhaslimitedadvertisingexpenses,whichgivesitenoughleewaytopasson
thesavingsfromloweradspendsbywayoflowerprices.Thecompanyadvertisesinalimited
waynewstickers,regionalnewspapers,somedigitaladvertising,etc.,thoughgoingaheadit
might start other forms of advertising too. Patanjali has adopted the unique information
basedadvertising.Forinstance,thecompanyhighlightsthepositivesofcowsghee,which
automatically helps sale of Patanjali Ghee. In the recent past, the companys print
advertisinghasseenamarkedincrease.

Fig.3:PatanjalisinformativeprintadvertisementsKeshKantiandGhee













Source:Company,Edelweissresearch

6 EdelweissSecuritiesLimited
PatanjaliAyurved

For the consumers, Baba Ramdev remains the face of Patanjali and its products. Baba
Ramdev, during his yoga sessions, showcases the Patanjali products. After the session, he
makes the attendees aware of the benefits of using Patanjali products. Till date, close to
70mn people have come in contact with Baba Ramdev through his yoga camps and it is
believed that this can increase to 200mn going ahead. This highlights the potential reach
that the Patanjali brands can have without much mainstream advertising. Also, being
associatedwithBabaRamdevhelpsincreatingabetterperceptionamongconsumersthat
beingayurvedicofferings,thePatanjaliproductsarehealthy.

Fig.4:BabaRamdevpromotingPatanjaliproducts


Source:Company,Edelweissresearch

Onlineplatformtospruceupdistributionnetwork
ManypeoplecomplainthatduetoPatanjalisweakdistributionnetworkitsproductsarenot
easily available everywhere and they are unable to buy them. To address this concern, the
companyhaschalkedoutanaggressiveplantoimproveitspresenceontheonlineplatform.
Currently, it is already selling its products through its website,
www.patanjaliayurved.net, from where consumers can order the products and get
free delivery of the same if the order value exceeds INR499. Other companies like
bigbasket.com, etc., that also sell Patanjali products online have been barred from doing
so. The company is also implementing ERP for better mapping of inventory (SAP has
already been implemented). Patanjali will also be launching its mobile app, which will
allow consumers to locate nearby outlets that are selling Patanjali products and also
facilitateonlineorderingofproducts.

Patanjali also sells its products through the Patanjali Chikitsalayas (where free medical
consultancyisgivenbymedicalpractioners),PatanjaliArogyaKendras(healthandwellness
centre)andSwadeshiKendras(regularoutlet).Asforreach,thecompanyhascloseto0.2mn
outlets and 10,000 franchisee model of Chikitshalyas and Arogya Kendras. Distribution
wise, the company operates through 100 super distributors (this will be bolstered going
forward)whointurnsupplytothewholesalersandretailers(whooperatethrougha500600
strongsalesteam).Asofnow,thecompanyhasnoplanstohavedirectreach.





7 EdelweissSecuritiesLimited
ConsumerGoods

Fig.5:Patanjaliayurved.net


Source:Company,Edelweissresearch

Apart from online presence, Patanjali is also taking steps to enhance its overall distributor
coverage. The company has invited applications for distributorship of its products. Being
seizedofthefactthatthatthereishighdemandforitsproducts,Patanjaliisnowoffering
separatedistributorshipforfoodandcosmeticscomparedtotheearliersystemwhenone
distributormanagedboth.Also,thecompanyisgivingdistributorshipatthedistrict,tehsil
andmandilevels,whichshowsitsconfidenceonitsthegrowthtrajectoryanddemandfor
itsproducts.














8 EdelweissSecuritiesLimited
PatanjaliAyurved

Fig.6:ApplicationformfordistributorshipofPatanjaliproducts(availableonline)


Source:Company,Edelweissresearch





9 EdelweissSecuritiesLimited
ConsumerGoods

Newproductspipelinestrongandinnovative
Patanjalihasaseparateteamfornewproductdevelopment.Thecompanyhasbeenableto
leave a mark owing to the pace and frequency of new product launches. Its robust R&D
department has churned out new products in quick time and lower costs. For instance,
Patanjali started working on its own brand of instant noodles post the Maggi issue and
withinaperiodof3monthsitisnowreadywithitsowninstantnoodles.Theproducthas
beensentforapprovalandisexpectedtobelaunchedwithinaperiodofonemonth(wegot
achancetotastetheproductandreallylikedit).Thecompanyhasarobustandinnovative
pipelineofnewproductswithsomesetforlaunchsoonandsomeothersatR&Dphase.

Newproductsthatareexpectedtobelaunchedsoon:
PatanjaliNoodles(willcompetewithinstantnoodleplayerslikeNestleandITC).

Dant Kanti Advance (already has 3 variants of Dant Kanti toothpaste Regular,
Medicated(similartosensitive)andJunior).

PowerVita(willprovidecompetitiontoallhealthfooddrinkcompanies(Mondelez,GSK
Consumer)thisproductismadeupofayurvedicingredientslikeBrahmi,etc.).
SugarFreeChyawanprash(competitiontochyawanprashmanufacturingcompanieslike
DaburandEmami).

Seabuck thorn dietary supplement in collaboration with DRDO (made under a


technologysharingagreementwithDRDO(usedbyarmypersonnelintoughterrainsas
asourceofnutrients)).Thisproductwillhaverichnessofallthenecessarynutrientsand
willbemadeavailabletocivilians).
Powdered hair dye (the company has a separate unit, Coloroma, which manufactures
herbalcoloursanddyes).

Divyapay(healthdrinkcomparabletotea)indipdipformat.

Child range (the company is also planning to launch a childrens range under Patanjali
whichwillincludeproductslikebabyoil,talcumpowder,babysoap,shampoo,etc).

ProductsatR&Dphase
Buttermilkinpowderform.

Oatswithmasala.

Chicorycoffee(caffeinefree).

Weightgainandlossproducts.

Madhuramgingerandroseflavor.










10 EdelweissSecuritiesLimited
PatanjaliAyurved

PatanjaliFoodandHerbalPark:Oneofthebiggestworldclassfacility
PatanjaliFoodandHerbalParkisoneofthelargestfoodparkintheworldspreadover150
acres.Constructionoftheparkwascompletedinrecordtimeof10monthsandtheparkhas
beeninoperationforover5yearsnow(parkconstructionstartedinFeb2009anditstarted
operationsinJanuary2010).

Patanjali has 3 manufacturing units in Haridwar (we visited the largest one, Unit 3).
Productionatunit3isdividedinto3parts:(1)food,(2)cosmetics;and(3)digestivesandRTS.
Gheeandayurvedicmedicinesaremanufacturedattheother2manufacturingunits.

ItisaworldclassplantequippedwiththebestmachineryinstalledbycompanieslikeTetra
Pack, Alfa Laval etc. As far as manufacturing is concerned, Patanjali does 90%
manufacturing inhouse. However, going ahead to meet demand and therefore enhance
capacityitisopentoeventhirdpartymanufacturingoropeningnewplants.Thecompany
has zero waste technology wherein whatever is left after usage of the raw material is
furtherprocessedforfurtherusage.Thisparkemployscloseto10,000personnel(fromin
andaroundthecitywithinaradiusof25kms).

Fig.7:PatanjaliFoodandHerbalPark


Source:Company,Edelweissresearch

RobustR&Densuresqualityandnewproductdevelopment
DuringourplantvisitwealsovisitedPatanjalisR&Dfacility,whichiswellequippedwithall
the latest machinery necessary for testing the products. The company has a separate R&D
department for each of the production units where the manufactured products are tested.
The company also has a highend central R&D facility situated at the park. This facility
ensures the products meet high quality standards and is undertakes R&D for new product
development.


11 EdelweissSecuritiesLimited
ConsumerGoods

Organisationalculture:Buildingblocks
ThoughPatanjalimightnotberegardedasacompletecorporatesetup,butthecompanyhas
been taking significant steps to professionalise the management and incorporating the
necessary processes and technology in the work culture. Patanjali is emerging as an
Employer of Choice as many professionals are independently coming forward to work
withthecompany.Duringourvisitandinteractionswefoundthereanymanyprofessionals
whoaremanagingdifferentunitsandhavepastworkexperienceincompanieslikeDabur,
ShehnazHussain,SGHLabs,AlkemLaboratories,etc.Patanjaliiscurrentlyadvertisingfor
many positions. The company has tied up with all major hiring agencies like naukri.com,
linkedin,etc.,togetthebesttalentfromindustrytoworkforit.

As for the processes, the company is moving towards a KRAbased working system and is
definingitsprocessesandinternalcontrolsystems.SAPhasalreadybeenimplementedwhich
hasledtoautomationinmajorityoftheprocesses.Thecompanyiscurrentlyintheprocess
to implementing ERP. Overall, the organisational culture is very employee friendly as the
company engages in a lot of training and development programmes for its employees. It
alsoengagesincareercounsellingandmentoringactivities.































12 EdelweissSecuritiesLimited
PatanjaliAyurved
EdelweissSecuritiesLimited,EdelweissHouse,offC.S.T.Road,Kalina,Mumbai400098.
Board:(9122)40094400,Email:research@edelweissfin.com

NiravSheth
HeadResearch
nirav.sheth@edelweissfin.com

Coveragegroup(s)ofstocksbyprimaryanalyst(s):ConsumerGoods
AsianPaints,BajajCorp,Colgate,Dabur,GodrejConsumer,Emami,HindustanUnilever,ITC,Marico,NestleLtd,PidiliteIndustries,GlaxoSmithKline
ConsumerHealthcare,UnitedSpirits

RecentResearch

Date Company Title Price(INR) Recos

30Sep15 Britannia MDmeettakeaways: 3,087 Not


Industries Reloadingthegrowthpunch; Rated
VisitNote
16Sep15 Dabur CEOmeetingtakeaways: 282 Buy
Bankingonhealthforfuture
wealth;VisitNote
07Sep15 Consumer GoingtheSMARTway;
Goodsand SectorUpdate
Retail

DistributionofRatings/MarketCap
EdelweissResearchCoverageUniverse RatingInterpretation

Buy Hold Reduce Total Rating Expectedto

RatingDistribution* 155 45 8 208 Buy appreciatemorethan15%overa12monthperiod
*stocksunderreview
Hold appreciateupto15%overa12monthperiod
>50bn Between10bnand50bn <10bn

Reduce depreciatemorethan5%overa12monthperiod
MarketCap(INR) 151 54 3

13 EdelweissSecuritiesLimited
ConsumerGoods
DISCLAIMER
EdelweissSecuritiesLimited(ESLorResearchEntity)isregulatedbytheSecuritiesandExchangeBoardofIndia(SEBI)andis
licensedtocarryonthebusinessofbroking,depositoryservicesandrelatedactivities.ThebusinessofESLanditsAssociates(list
available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME
Finance,Commodities,FinancialMarkets,AssetManagementandLifeInsurance.

This Report has been prepared by Edelweiss Securities Limited in the capacity of a Research Analyst having SEBI Registration
No.INH200000121anddistributedasperSEBI(ResearchAnalysts)Regulations2014.Thisreportdoesnotconstituteanofferor
solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Securities as
definedinclause(h)ofsection2oftheSecuritiesContracts(Regulation)Act,1956includesFinancialInstrumentsandCurrency
Derivatives.Theinformationcontainedhereinisfrompubliclyavailabledataorothersourcesbelievedtobereliable.Thisreportis
providedforassistanceonlyandisnotintendedtobeandmustnotalonebetakenasthebasisforaninvestmentdecision.The
userassumestheentireriskofanyusemadeofthisinformation.Eachrecipientofthisreportshouldmakesuchinvestigationasit
deemsnecessarytoarriveatanindependentevaluationofaninvestmentinSecuritiesreferredtointhisdocument(includingthe
merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The
investmentdiscussedorviewsexpressedmaynotbesuitableforallinvestors.

Thisinformationisstrictlyconfidentialandisbeingfurnishedtoyousolelyforyourinformation.Thisinformationshouldnotbe
reproducedorredistributedorpassedondirectlyorindirectlyinanyformtoanyotherpersonorpublished,copied,inwholeorin
part,foranypurpose.Thisreportisnotdirectedorintendedfordistributionto,oruseby,anypersonorentitywhoisacitizenor
residentoforlocatedinanylocality,state,countryorotherjurisdiction,wheresuchdistribution,publication,availabilityoruse
wouldbecontrarytolaw,regulationorwhichwouldsubjectESLandassociates/groupcompaniestoanyregistrationorlicensing
requirementswithinsuchjurisdiction.Thedistributionofthisreportincertainjurisdictionsmayberestrictedbylaw,andpersons
inwhosepossessionthisreportcomes,shouldobserve,anysuchrestrictions.Theinformationgiveninthisreportisasofthedate
ofthisreportandtherecanbenoassurancethatfutureresultsoreventswillbeconsistentwiththisinformation.Thisinformation
issubjecttochangewithoutanypriornotice.ESLreservestherighttomakemodificationsandalterationstothisstatementas
mayberequiredfromtimetotime.ESLoranyofitsassociates/groupcompaniesshallnotbeinanywayresponsibleforanyloss
ordamagethatmayarisetoanypersonfromanyinadvertenterrorintheinformationcontainedinthisreport.ESLiscommitted
toprovidingindependentandtransparentrecommendationtoitsclients.NeitherESLnoranyofitsassociates,groupcompanies,
directors,employees,agentsorrepresentativesshallbeliableforanydamageswhetherdirect,indirect,specialorconsequential
including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary
trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed
herein.Pastperformanceisnotnecessarilyaguidetofutureperformance.Thedisclosuresofintereststatementsincorporatedin
thisreportareprovidedsolelytoenhancethetransparencyandshouldnotbetreatedasendorsementoftheviewsexpressedin
thereport.Theinformationprovidedinthesereportsremains,unlessotherwisestated,thecopyrightofESL.Alllayout,design,
originalartwork,conceptsandotherIntellectualProperties,remainsthepropertyandcopyrightofESLandmaynotbeusedin
anyformorforanypurposewhatsoeverbyanypartywithouttheexpresswrittenpermissionofthecopyrightholders.

ESLshallnotbeliableforanydelayoranyotherinterruptionwhichmayoccurinpresentingthedataduetoanyreasonincluding
network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown,
maintenanceshutdown,breakdownofcommunicationservicesorinabilityoftheESLtopresentthedata.InnoeventshallESLbe
liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or
expensesarisinginconnectionwiththedatapresentedbytheESLthroughthisreport.

We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers
simultaneously,notallcustomersmayreceivethisreportatthesametime.Wewillnottreatrecipientsascustomersbyvirtueof
theirreceivingthisreport.

ESLand itsassociates, officer,directors,and employees,researchanalyst(includingrelatives)worldwide may:(a)fromtimeto


time,havelongorshortpositionsin,andbuyorselltheSecurities,mentionedhereinor(b)beengagedinanyothertransaction
involvingsuchSecuritiesandearnbrokerageorothercompensationoractasamarketmakerinthefinancialinstrumentsofthe
subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other
potential/materialconflictofinterestwithrespecttoanyrecommendationandrelatedinformationandopinionsatthetimeof
publication of research report or at the time of public appearance. ESL may have proprietary long/short position in the above
mentionedscrip(s)andthereforeshouldbeconsideredasinterested.Theviewsprovidedhereinaregeneralinnatureanddonot
considerriskappetiteorinvestmentobjectiveofanyparticularinvestor;readersarerequestedtotakeindependentprofessional
advicebeforeinvesting.ThisshouldnotbeconstruedasinvitationorsolicitationtodobusinesswithESL.

14 EdelweissSecuritiesLimited
PatanjaliAyurved

ESLoritsassociatesmayhavereceivedcompensationfromthesubjectcompanyinthepast12months.ESLoritsassociatesmay
havemanagedorcomanagedpublicofferingofsecuritiesforthesubjectcompanyinthepast12months.ESLoritsassociates
mayhavereceivedcompensationforinvestmentbankingormerchantbankingorbrokerageservicesfromthesubjectcompanyin
the past 12 months. ESL or its associates may have received any compensation for products or services other than investment
bankingormerchantbankingorbrokerageservicesfromthesubjectcompanyinthepast12months.ESLoritsassociateshave
notreceivedanycompensationorotherbenefitsfromtheSubjectCompanyorthirdpartyinconnectionwiththeresearchreport.
Researchanalystorhis/herrelativeorESLsassociatesmayhavefinancialinterestinthesubjectcompany.ESLand/oritsGroup
Companies, their Directors, affiliates and/or employees may have interests/ positions, financial or otherwise in the
Securities/Currencies and other investment products mentioned in this report. ESL, its associates, research analyst and his/her
relativemayhaveotherpotential/materialconflictofinterestwithrespecttoanyrecommendationandrelatedinformationand
opinionsatthetimeofpublicationofresearchreportoratthetimeofpublicappearance.
Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange
rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market
factors,includingworldandnationaleconomic,politicalandregulatoryevents,eventsinequityanddebtmarketsandchangesin
interestrates;and(iii)currenciesmaybesubjecttodevaluationorgovernmentimposedexchangecontrolswhichcouldaffectthe
valueofthecurrency.InvestorsinsecuritiessuchasADRsandCurrencyDerivatives,whosevaluesareaffectedbythecurrencyof
anunderlyingsecurity,effectivelyassumecurrencyrisk.
Researchanalysthasservedasanofficer,directororemployeeofsubjectCompany:No
ESLhasfinancialinterestinthesubjectcompanies:No
ESLsAssociatesmayhaveactual/beneficialownershipof1%ormoresecuritiesofthesubjectcompanyattheendofthemonth
immediatelyprecedingthedateofpublicationofresearchreport.
Researchanalystorhis/herrelativehasactual/beneficialownershipof1%ormoresecuritiesofthesubjectcompanyattheendof
themonthimmediatelyprecedingthedateofpublicationofresearchreport:No
ESL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately
precedingthedateofpublicationofresearchreport:No
Subjectcompanymayhavebeenclientduringtwelvemonthsprecedingthedateofdistributionoftheresearchreport.
There were no instances of noncompliance by ESL on any matter related to the capital markets, resulting in significant and
materialdisciplinaryactionduringthelastthreeyearsexceptthatESLhadsubmittedanofferofsettlementwithSecuritiesand
Exchangecommission,USA(SEC)andthesamehasbeenacceptedbySECwithoutadmittingordenyingthefindingsinrelationto
theirchargesofnonregistrationasabrokerdealer.
Agraphofdailyclosingpricesofthesecuritiesisalsoavailableatwww.nseindia.com
AnalystCertification:
Theanalystforthisreportcertifiesthatalloftheviewsexpressedinthisreportaccuratelyreflecthisorherpersonalviewsabout
thesubjectcompanyorcompaniesanditsortheirsecurities,andnopartofhisorhercompensationwas,isorwillbe,directlyor
indirectlyrelatedtospecificrecommendationsorviewsexpressedinthisreport.

AdditionalDisclaimers

DisclaimerforU.S.Persons
This research report is a product of Edelweiss Securities Limited, which is the employer of the research analyst(s) who has
prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States
(U.S.) and are not associated persons of any U.S. regulated brokerdealer and therefore the analyst(s) is/are not subject to
supervisionbyaU.S.brokerdealer,andis/arenotrequiredtosatisfytheregulatorylicensingrequirementsofFINRAorrequired
tootherwisecomplywithU.S.rulesorregulationsregarding,amongotherthings,communicationswithasubjectcompany,public
appearancesandtradingsecuritiesheldbyaresearchanalystaccount.

ThisreportisintendedfordistributionbyEdelweissSecuritiesLimitedonlyto"MajorInstitutionalInvestors"asdefinedbyRule
15a6(b)(4)oftheU.S.SecuritiesandExchangeAct,1934(theExchange Act)andinterpretationsthereof byU.S.Securitiesand
ExchangeCommission(SEC)inrelianceonRule15a6(a)(2).IftherecipientofthisreportisnotaMajorInstitutionalInvestoras
specifiedabove,thenitshouldnotactuponthisreportandreturnthesametothesender.Further,thisreportmaynotbecopied,
duplicatedand/ortransmittedonwardtoanyU.S.person,whichisnottheMajorInstitutionalInvestor.

15 EdelweissSecuritiesLimited
ConsumerGoods

InrelianceontheexemptionfromregistrationprovidedbyRule15a6oftheExchangeActandinterpretationsthereofbytheSEC
in order to conduct certain business with Major Institutional Investors, Edelweiss Securities Limited has entered into an
agreementwithaU.S.registeredbrokerdealer,EdelweissFinancialServicesInc.("EFSI").Transactionsinsecuritiesdiscussedin
thisresearchreportshouldbeeffectedthroughEdelweissFinancialServicesInc.

DisclaimerforU.K.Persons
The contents of this research report have not been approved by an authorised person within the meaning of the Financial
ServicesandMarketsAct2000("FSMA").

IntheUnitedKingdom,thisresearchreportisbeingdistributedonlytoandisdirectedonlyat(a)personswhohaveprofessional
experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the
Order);(b)personsfallingwithinArticle49(2)(a)to(d)oftheOrder(includinghighnetworthcompaniesandunincorporated
associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being
referredtoasrelevantpersons).

Thisresearchreportmustnotbeactedonorreliedonbypersonswhoarenotrelevantpersons.Anyinvestmentorinvestment
activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant
persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This
research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other
person.

DisclaimerforCanadianPersons
ThisresearchreportisaproductofEdelweissSecuritiesLimited("ESL"),whichistheemployeroftheresearchanalystswhohave
preparedtheresearchreport.TheresearchanalystspreparingtheresearchreportareresidentoutsidetheCanadaandarenot
associatedpersonsofanyCanadianregisteredadviserand/ordealerand,therefore,theanalystsarenotsubjecttosupervisionby
aCanadianregisteredadviserand/ordealer,andarenotrequiredtosatisfytheregulatorylicensingrequirementsoftheOntario
Securities Commission, other Canadian provincial securities regulators, the Investment Industry Regulatory Organization of
CanadaandarenotrequiredtootherwisecomplywithCanadianrulesorregulationsregarding,amongotherthings,theresearch
analysts'businessorrelationshipwithasubjectcompanyortradingofsecuritiesbyaresearchanalyst.

ThisreportisintendedfordistributionbyESLonlyto"PermittedClients"(asdefinedinNationalInstrument31103("NI31103"))
who are resident in the Province of Ontario, Canada (an "Ontario Permitted Client"). If the recipient of this report is not an
OntarioPermittedClient,asspecifiedabove,thentherecipientshouldnotactuponthisreportandshouldreturnthereportto
thesender.Further,thisreportmaynotbecopied,duplicatedand/ortransmittedonwardtoanyCanadianperson.

ESL is relying on an exemption from the adviser and/or dealer registration requirements under NI 31103 available to certain
international advisers and/or dealers. Please be advised that (i) ESL is not registered in the Province of Ontario to trade in
securities nor is it registered in the Province of Ontario to provide advice with respect to securities; (ii) ESL's head office or
principal place of business is located in India; (iii) all or substantially all of ESL's assets may be situated outside of Canada; (iv)
theremaybedifficultyenforcinglegalrightsagainstESLbecauseoftheabove;and(v)thenameandaddressoftheESL'sagentfor
serviceofprocessintheProvinceofOntariois:BamacServicesInc.,181BayStreet,Suite2100,Toronto,OntarioM5J2T3Canada.

DisclaimerforSingaporePersons
In Singapore, this report is being distributed by Edelweiss Investment Advisors Private Limited ("EIAPL") (Co. Reg. No.
201016306H)whichisaholderofacapitalmarketsserviceslicenseandanexemptfinancialadviserinSingaporeand(ii)solelyto
personswhoqualifyas"institutionalinvestors"or"accreditedinvestors"asdefinedinsection4A(1)oftheSecuritiesandFutures
Act,Chapter289ofSingapore("theSFA").Pursuanttoregulations33,34,35and36oftheFinancialAdvisersRegulations("FAR"),
sections 25, 27 and 36 of the Financial Advisers Act, Chapter 110 of Singapore shall not apply to EIAPL when providing any
financialadvisoryservicestoanaccreditedinvestor(asdefinedinregulation36oftheFAR.PersonsinSingaporeshouldcontact
EIAPLinrespectofanymatterarisingfrom,orinconnectionwiththispublication/communication.Thisreportisnotsuitablefor
privateinvestors.
Copyright2009EdelweissResearch(EdelweissSecuritiesLtd).Allrightsreserved

AccesstheentirerepositoryofEdelweissResearchonwww.edelresearch.com

16 EdelweissSecuritiesLimited

You might also like